Skip to content

Cervical Cancer Screening Study

Clinical studies and in-depth interviews for portable, low-cost, and speculum-free cervical cancer screening in Ghana.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201905806116817
Enrollment
100
Registered
2019-05-06
Start date
2019-04-23
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Cervical Cancer

Interventions

Use of Callascope to take an image of the cervix before standard ofcare procedure

Sponsors

Mercy Asiedu
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria • Patients undergoing cervicography OR colposcopy OR VIA OR patients undergoing LEEP for the treatment of cervical cancer. • Age 21 and greater • Patients of all ethnicities will be included. • Ability to understand and the willingness to sign a written informed consent document. • Fluent in English, Ga or Asante Twi.

Exclusion criteria

Exclusion criteria: Exclusion criteria: • Subjects under 21. • Pregnant women in their 2nd and 3rd trimesters • Women who are on their periods

Design outcomes

Primary

MeasureTime frame
Feasibility of visualizing cervix;Cervix visualization of Callascope compared to speculum;Concordance of diagnosis using Callascope image compared to standard of care ;Ease of use;Patient acceptability;Understand Knowledge and beliefs around reproductive health and cervical cancer, perceptions towards speculum and Callascope

Secondary

MeasureTime frame
Safety

Countries

Ghana

Contacts

Public ContactMercy Asiedu

Graduate Research Assistant

mercy.asiedu@duke.edu+233246649599

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026